Exploratory study of detection of mutated EGFR from plasma of patients with EGFR mutant non-small cell lung cancer resistant to EGFR-TKI.

Not Applicable

• Conditions: on-small cell lung cancer (NSCLC)

• Registration Number: JPRN-UMIN000007817
• Lead Sponsor: Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-05-14
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 26

Inclusion Criteria

Not provided

Exclusion Criteria

1) Interstital pneumonitis 2) Uncontrolled intercurrent illness 3) Active infection 4) Need for treatment within 6 months for double cancer 5) Symptomatic CNS metastases 6) Massive pleural effusion or ascites 7) History of irradiation to more than half of pelvic bone 8) Allergy to treatment drugs 9) Pregnant or breast-feeding 10) Unwilling to use adequate contraception 11) Other conditions inadequate for this research

Study & Design

• Study Type: Interventional
• Study Design: Not specified